-
2
-
-
79953166862
-
Tiotropium versus salmeterol for the prevention of exacerbations of COPD
-
Vogelmeier C, Hederer B, Glaab T, et al. Tiotropium versus salmeterol for the prevention of exacerbations of COPD. N Engl J Med 2011; 364: 1093-1103.
-
(2011)
N Engl J Med
, vol.364
, pp. 1093-1103
-
-
Vogelmeier, C.1
Hederer, B.2
Glaab, T.3
-
3
-
-
33847172367
-
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease
-
Calverley PM, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356: 775-789.
-
(2007)
N Engl J Med
, vol.356
, pp. 775-789
-
-
Calverley, P.M.1
Anderson, J.A.2
Celli, B.3
-
4
-
-
79953283384
-
Combination inhaled steroid and long-acting β2-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease
-
Karner C, Cates CJ. Combination inhaled steroid and long-acting β2-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2011; 3: CD008532.
-
(2011)
Cochrane Database Syst Rev
, vol.3
, pp. CD008532
-
-
Karner, C.1
Cates, C.J.2
-
5
-
-
84878922304
-
Guideline adherence in management of stable chronic obstructive pulmonary disease
-
Sharif R, Cuevas CR, Wang Y, et al. Guideline adherence in management of stable chronic obstructive pulmonary disease. Respir Med 2013; 107: 1046-1052.
-
(2013)
Respir Med
, vol.107
, pp. 1046-1052
-
-
Sharif, R.1
Cuevas, C.R.2
Wang, Y.3
-
6
-
-
84897405184
-
Real-life use of inhaled corticosteroids in COPD patients versus the GOLD proposals: A paradigm shift in GOLD 2011
-
Burgel PR, Deslée G, Jebrak G, et al. Real-life use of inhaled corticosteroids in COPD patients versus the GOLD proposals: a paradigm shift in GOLD 2011? Eur Respir J 2014; 43: 1201-1203.
-
(2014)
Eur Respir J
, vol.43
, pp. 1201-1203
-
-
Burgel, P.R.1
Deslée, G.2
Jebrak, G.3
-
7
-
-
79958816304
-
Variation in adherence with Global Initiative for Chronic Obstructive Lung Disease (GOLD) drug therapy guidelines: A retrospective actuarial claims data analysis
-
Fitch K, Iwasaki K, Pyenson B, et al. Variation in adherence with Global Initiative for Chronic Obstructive Lung Disease (GOLD) drug therapy guidelines: a retrospective actuarial claims data analysis. Curr Med Res Opin 2011; 27: 1425-1429.
-
(2011)
Curr Med Res Opin
, vol.27
, pp. 1425-1429
-
-
Fitch, K.1
Iwasaki, K.2
Pyenson, B.3
-
8
-
-
84860767710
-
Impact of adherence to the GOLD guidelines on symptom prevalence, lung function decline and exacerbation rate in the Swiss COPD cohort
-
Jochmann A, Scherr A, Jochmann DC, et al. Impact of adherence to the GOLD guidelines on symptom prevalence, lung function decline and exacerbation rate in the Swiss COPD cohort. Swiss Med Wkly 2012; 142: w13567.
-
(2012)
Swiss Med Wkly
, vol.142
, pp. w13567
-
-
Jochmann, A.1
Scherr, A.2
Jochmann, D.C.3
-
9
-
-
84860304497
-
Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids
-
Asche CV, Leader S, Plauschinat C, et al. Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids. Int J Chron Obstruct Pulmon Dis 2012; 7: 201-209.
-
(2012)
Int J Chron Obstruct Pulmon Dis
, vol.7
, pp. 201-209
-
-
Asche, C.V.1
Leader, S.2
Plauschinat, C.3
-
10
-
-
84875820681
-
How and when to use inhaled corticosteroids in chronic obstructive pulmonary disease
-
Antón E. How and when to use inhaled corticosteroids in chronic obstructive pulmonary disease? Expert Rev Respir Med 2013; 7: 25-32.
-
(2013)
Expert Rev Respir Med
, vol.7
, pp. 25-32
-
-
Antón, E.1
-
11
-
-
84905639968
-
The effect of roflumilast in addition to LABA/LAMA/ICS treatment in COPD patients
-
De Backer W, Vos W, Van Holsbeke C, et al. The effect of roflumilast in addition to LABA/LAMA/ICS treatment in COPD patients. Eur Respir J 2014; 44: 527-529.
-
(2014)
Eur Respir J
, vol.44
, pp. 527-529
-
-
De Backer, W.1
Vos, W.2
Van Holsbeke, C.3
-
12
-
-
84905667274
-
Bifunctional drugs for the treatment of asthma and chronic obstructive pulmonary disease
-
Page C, Cazzola M. Bifunctional drugs for the treatment of asthma and chronic obstructive pulmonary disease. Eur Respir J 2014; 44: 475-482.
-
(2014)
Eur Respir J
, vol.44
, pp. 475-482
-
-
Page, C.1
Cazzola, M.2
-
13
-
-
84895548677
-
A comparison of the efficacy and safety of once-daily fluticasone furoate/vilanterol with twice-daily fluticasone propionate/salmeterol in moderate to very severe COPD
-
Agustí A, de Teresa L, De Backer W, et al. A comparison of the efficacy and safety of once-daily fluticasone furoate/vilanterol with twice-daily fluticasone propionate/salmeterol in moderate to very severe COPD. Eur Respir J 2014; 43: 763-772.
-
(2014)
Eur Respir J
, vol.43
, pp. 763-772
-
-
Agustí, A.1
De Teresa, L.2
De Backer, W.3
-
14
-
-
84879524095
-
Long-term macrolide treatment for chronic respiratory disease
-
Spagnolo P, Fabbri LM, Bush A. Long-term macrolide treatment for chronic respiratory disease. Eur Respir J 2013; 42: 239-251.
-
(2013)
Eur Respir J
, vol.42
, pp. 239-251
-
-
Spagnolo, P.1
Fabbri, L.M.2
Bush, A.3
|